×
Back to Agenda
Remote Implementation of Clinical Outcome Assessments During the COVID-19 Pandemic and Beyond
Session Chair(s)
Elektra Papadopoulos, MD, MPH
Director, Patient Experience Data and Strategy, AbbVie, United States
Remote clinical outcome assessments (COAs) enable conduct of decentralized trials and played a pivotal role in adapting trials during the COVID-19 pandemic. A multi-stakeholder panel will discuss considerations for implementing COAs remotely.
Learning Objective : Describe considerations for remote implementation of COAs during and after COVID-19; Discuss opportunities and challenges to implement remote COAs in clinical trials; Discuss key aspects of data collection and analysis when using remote COAs.
Speaker(s)
Isaac R Rodriguez-Chavez, MHS, PHD, MS
, 4Biosolutions Consulting, United States
Industry Update
Maria Tome, MD, PHD, FFPM
Pharma Medicine Physician, Senior Scientific Advisor, Scientific Advice, European Medicines Agency, Netherlands
EMA Update
Kai Langel
Senior Director, Strategy and Innovation, Global Regulatory Policy, Janssen, Spain
Industry Update
Have an account?